4x6j
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3Y2:2-AMINO-4-CHLORO-N-(1-{[(2E)-2-IMINOETHYL]CARBAMOYL}CYCLOHEXYL)BENZAMIDE'>3Y2</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=PGO:S-1,2-PROPANEDIOL'>PGO</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3Y2:2-AMINO-4-CHLORO-N-(1-{[(2E)-2-IMINOETHYL]CARBAMOYL}CYCLOHEXYL)BENZAMIDE'>3Y2</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=PGO:S-1,2-PROPANEDIOL'>PGO</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Cathepsin_K Cathepsin K], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.38 3.4.22.38] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Cathepsin_K Cathepsin K], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.38 3.4.22.38] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x6j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x6j OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4x6j RCSB], [http://www.ebi.ac.uk/pdbsum/4x6j PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x6j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x6j OCA], [http://pdbe.org/4x6j PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x6j RCSB], [http://www.ebi.ac.uk/pdbsum/4x6j PDBsum]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 19: | Line 19: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4x6j" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 06:08, 30 September 2015
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.
|
Categories: Cathepsin K | Borisek, J | Mohar, B | Novic, M | Sosnowski, P | Turk, B | Turk, D | Vizovisek, M | Cathepsin k | Hydrolase | Inhibitor